This news section is designed to aggregate online, magazine and newspaper articles written about keratoconus.
Carlsbad, CA (January 22, 2013) SynergEyes, Inc., the leader in hybrid contact lens technology, announced that UltraHealth®, its next generation hybrid contact lens for patients with irregular corneas and keratoconus, launched at Global Specialty Lens Symposium- January 24, 2013, at the Rio Hotel & Casino, Las Vegas, Nevada.
The new UltraHealth®, made from high oxygen permeable (Dk) silicone-hydrogel material, is a hybrid lens designed for emerging, mid-stage, and advanced keratoconus. The design concept is in the form of reverse geometry including a combination of a soft skirt (Dk 84) and central RGP material (Dk 130).
Continue ReadingSan Diego, CA (January 5, 2013) – SynergEyes, Inc., the leader in hybrid contact lens technology, announced that it will continue to be a major sponsor of the National Keratoconus Foundation (NKCF), a Patient Outreach and Education Program of the non-profit organization Discovery Eye Foundation.
As the inventor of the first hybrid contact lens with FDA-clearance specifically designed for patients with keratoconus, SynergEyes supports the mission of the NKCF to improve the quality of life of persons with keratoconus by making educational material available to them,
Continue ReadingCarlsbad, CA (December 20, 2010) – This holiday season patients are receiving the life-changing gift of clear and comfortable vision thanks to the Sharing Vision Grant Program sponsored by SynergEyes, Inc. This program was created to bring the new technologically advanced ClearKone® hybrid contact lens to keratoconus patients who may otherwise not have access. Keratoconus is a degenerative eye disease that occurs 1 in 1,000 people causing substantially distorted vision and in many cases changes how they live their lives.
Continue ReadingWaltham, MA—A thermo-biomechanical system (Vedera, Avedro) for performing a proprietary procedure (Keraflex) to flatten the cornea in the treatment of myopia and keratoconus has received the European Union (EU) CE mark.
“CE mark certification is an important milestone for the company and also represents a vital new offering to ophthalmic patients and their physicians,” said David Muller, PhD, president and chief executive officer of Avedro.
Through the noninvasive, incisionless procedure performed by the device,
Continue Reading